UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The molecular pathogenesis of head and neck squamous cell carcinoma

The Journal of clinical investigation, 2012-06, Vol.122 (6), p.1951-1957

2012

Volltextzugriff (PDF)

Revisiting Androgen Receptor Signaling in Breast Cancer

The oncologist (Dayton, Ohio), 2023-05, Vol.28 (5), p.383-391

2023

Volltextzugriff (PDF)

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq

Nature communications, 2018-09, Vol.9 (1), p.3588-10, Article 3588

2018

Volltextzugriff (PDF)

Loss of p53 and genetic evolution in pancreatic cancer: Ordered chaos after the guardian is gone

Cancer cell, 2022-11, Vol.40 (11), p.1276-1278

2022

Volltextzugriff (PDF)

Yap Tunes Airway Epithelial Size and Architecture by Regulating the Identity, Maintenance, and Self-Renewal of Stem Cells

Developmental cell, 2014-07, Vol.30 (2), p.151-165

2014

Volltextzugriff (PDF)

Novel antibody–drug conjugates for triple negative breast cancer

Therapeutic Advances in Medical Oncology, 2020, Vol.12, p.1758835920915980-1758835920915980

2020

Volltextzugriff (PDF)

Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling

Genes & development, 2008-01, Vol.22 (2), p.239-251

2008

Volltextzugriff (PDF)

ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis

Cancer cell, 2017-01, Vol.31 (1), p.35-49

2017

Volltextzugriff (PDF)

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

Nature genetics, 2017-10, Vol.49 (10), p.1476-1486

2017

Volltextzugriff (PDF)

A wound-healing program is hijacked to promote cancer metastasis

The Journal of experimental medicine, 2017-10, Vol.214 (10), p.2813-2815

Ellisen, Leif W

2017

Volltextzugriff (PDF)

Targeting TAp63 in Breast Cancer

Oncology (Williston Park, N.Y.), 2021-06, Vol.35 (6), p.368

Ellisen, Leif W

2021

Volltextzugriff (PDF)

Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1

Developmental cell, 2014-01, Vol.28 (2), p.147-160

2014

Volltextzugriff (PDF)

PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles

Cancer cell, 2011-02, Vol.19 (2), p.165-167

Ellisen, Leif W.

2011

Volltextzugriff (PDF)

Immune activation and evolution through chemotherapy plus checkpoint blockade in triple-negative breast cancer

Cancer cell, 2021-12, Vol.39 (12), p.1562-1564

2021

Volltextzugriff (PDF)

Bioprinting the Cancer Microenvironment

ACS biomaterials science & engineering, 2016-10, Vol.2 (10), p.1710-1721

2016

Volltextzugriff (PDF)

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence

Journal of clinical oncology, 2015-11, Vol.33 (31), p.3621-3627

2015

Volltextzugriff (PDF)

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer

Cancer discovery, 2021-10, Vol.11 (10), p.2436-2445

2021

Volltextzugriff (PDF)

Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad‐Based Tumor Genotyping

The oncologist (Dayton, Ohio), 2012-01, Vol.17 (1), p.72-79

2012

Volltextzugriff (PDF)

Cognitive Computing to Guide Molecular‐Based Therapy Selection: Steps Forward amid Abundant Need

The oncologist (Dayton, Ohio), 2018-02, Vol.23 (2), p.145-146

Ellisen, Leif W.

2018

Volltextzugriff (PDF)

A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity

Nature communications, 2015-04, Vol.6 (1), p.7014-7014, Article 7014

2015

Volltextzugriff (PDF)

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

Journal of clinical oncology, 2010-03, Vol.28 (7), p.1145-1153

2010

Volltextzugriff (PDF)

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

JAMA oncology, 2015-10, Vol.1 (7), p.943

2015

Volltextzugriff (PDF)

PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition

Cancer discovery, 2012-11, Vol.2 (11), p.1036-1047

2012

Volltextzugriff (PDF)

Mechanisms of Resistance to Antibody-Drug Conjugates

Cancers, 2023-02, Vol.15 (4), p.1278

2023

Volltextzugriff (PDF)

REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors

Genes & development, 2020-06, Vol.34 (11-12), p.751-766

2020

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Englisch
(219)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(58)
Journal Of Clinical Oncology
(31)
Clinical Cancer Research
(10)
The Oncologist
(7)
The oncologist
(7)
The Journal Of Clinical Investigation
(6)
Cancer Cell
(5)
Cancer Discovery
(5)
Cell
(5)
Genes & Development
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The molecular pathogenesis of head and neck squamous cell carcinoma

Revisiting Androgen Receptor Signaling in Breast Cancer

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq

Loss of p53 and genetic evolution in pancreatic cancer: Ordered chaos after the guardian is gone

Yap Tunes Airway Epithelial Size and Architecture by Regulating the Identity, Maintenance, and Self-Renewal of Stem Cells

Novel antibody–drug conjugates for triple negative breast cancer

Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling

ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

A wound-healing program is hijacked to promote cancer metastasis

Targeting TAp63 in Breast Cancer

Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1

PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles

Immune activation and evolution through chemotherapy plus checkpoint blockade in triple-negative breast cancer

Bioprinting the Cancer Microenvironment

Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence

Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer

Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad‐Based Tumor Genotyping

Cognitive Computing to Guide Molecular‐Based Therapy Selection: Steps Forward amid Abundant Need

A REDD1/TXNIP pro-oxidant complex regulates ATG4B activity to control stress-induced autophagy and sustain exercise capacity

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment

PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition

Mechanisms of Resistance to Antibody-Drug Conjugates

REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors

Suchergebnisse filtern